» Articles » PMID: 19624684

Hybrid Mathematical Model of Glioma Progression

Overview
Journal Cell Prolif
Date 2009 Jul 24
PMID 19624684
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Gliomas are an important form of brain cancer, with high mortality rate. Mathematical models are often used to understand and predict their behaviour. However, using current modeling techniques one must choose between simulating individual cell behaviour and modeling tumours of clinically significant size.

Materials And Methods: We propose a hybrid compartment-continuum-discrete model to simulate glioma growth and malignant cell invasion. The discrete portion of the model is capable of capturing intercellular interactions, including cell migration, intercellular communication, spatial cell population heterogeneity, phenotype differentiation, epigenetic events, proliferation, and apoptosis. Combining this with a compartment and continuum model allows clinically significant tumour sizes to be evaluated.

Results And Conclusions: This model is used to perform multiple simulations to determine sensitivity to changes in important model parameters, specifically, the fundamental length parameter, necrotic cell degradation rate, rate of cell migration, and rate of phenotype transformation. Using these values, the model is able to simulate tumour growth and invasion behaviour, observed clinically. This mathematical model provides a means to simulate various tumour development scenarios, which may lead to a better understanding of how altering fundamental parameters can influence neoplastic progression.

Citing Articles

A dynamical model of combination therapy applied to glioma.

Handoko H, Tri Wahyudi S, Setyawan A, Kartono A J Biol Phys. 2022; 48(4):439-459.

PMID: 36367670 PMC: 9727046. DOI: 10.1007/s10867-022-09618-8.


Coupling solid and fluid stresses with brain tumour growth and white matter tract deformations in a neuroimaging-informed model.

Lucci G, Agosti A, Ciarletta P, Giverso C Biomech Model Mechanobiol. 2022; 21(5):1483-1509.

PMID: 35908096 PMC: 9626445. DOI: 10.1007/s10237-022-01602-4.


Spatiotemporal dynamics of a glioma immune interaction model.

Khajanchi S, Nieto J Sci Rep. 2021; 11(1):22385.

PMID: 34789751 PMC: 8599515. DOI: 10.1038/s41598-021-00985-1.


An Integrative and Modular Framework to Recapitulate Emergent Behavior in Cell Migration.

Cuenca M, Canedo L, Perez-Castro C, Grecco H Front Cell Dev Biol. 2021; 8:615759.

PMID: 33415111 PMC: 7783155. DOI: 10.3389/fcell.2020.615759.


Glioma growth modeling based on the effect of vital nutrients and metabolic products.

Papadogiorgaki M, Koliou P, Zervakis M Med Biol Eng Comput. 2018; 56(9):1683-1697.

PMID: 29516334 DOI: 10.1007/s11517-018-1809-0.


References
1.
Anderson A, Weaver A, Cummings P, Quaranta V . Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell. 2006; 127(5):905-15. DOI: 10.1016/j.cell.2006.09.042. View

2.
Floyd N, Woo S, Teh B, Prado C, Mai W, Trask T . Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004; 58(3):721-6. DOI: 10.1016/S0360-3016(03)01623-7. View

3.
Ganguly R, Puri I . Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis. Cell Prolif. 2007; 40(3):338-54. PMC: 6496895. DOI: 10.1111/j.1365-2184.2007.00434.x. View

4.
Oliver T, Wechsler-Reya R . Getting at the root and stem of brain tumors. Neuron. 2004; 42(6):885-8. DOI: 10.1016/j.neuron.2004.06.011. View

5.
Spence A, Muzi M, Graham M, OSullivan F, Krohn K, Link J . Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. J Nucl Med. 1998; 39(3):440-8. View